[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Top 10 Medical Device Technologies Market by Type (In Vitro Diagnostics, Diagnostics Imaging, Orthopedic, Ophthalmology, Cardiology, Endoscopy, Diabetes Care, Respiratory Care & Anesthesia, Kidney/Dialysis Devices) and Region - Global Forecast to 2027

May 2023 | 497 pages | ID: TDDFC537FC3EN
MarketsandMarkets

US$ 8,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global top 10 Medical Device Technologies market is projected to reach USD 577.5 billion by 2027 from USD 437.4 billion in 2022, at a CAGR of 5.7% during the forecast period. Globally, with the rapid growth in aging population, the incidence of a number of chronic diseases is on the rise. Moreover, the elderly is more susceptible to traumas and injuries. Due to these factors, the demand for advanced medical equipment is increasing across the globe.

The emerging markets in Asia-Pacific (India and China) and Latin America (Brazil and Mexico) are expected to offer significant growth opportunities in the coming years. The high growth in these markets can majorly be attributed to the rising geriatric population; growing prevalence of chronic diseases; improving healthcare infrastructure due to increasing investments by respective government bodies; and rising investments by leading players in these countries.

“The Cardiology Devices Market segment holds the second largest share in top 10 Medical Device Technologies market.”

The growth in the Cardiology Devices Market is mainly driven by the increasing incidences of cardiovascular diseases and launch of innovative products by market players. However, low affordability and inaccessibility of cardiac surgeries in developing countries is expected to restrain the growth of cardiology devices market during the forecast period.

“In the forecast period, global respiratory care & anesthesia devices market segment is expected to grow at the highest CAGR in the top 10 medical devices market”

During the forecast period, the global respiratory care & anesthesia devices segment is expected to grow at the highest CAGR. The increasing need for advanced and innovative machines and equipment and high incidence of chronic obstructive pulmonary diseases (COPD) and obtrusive sleep apnea (OSA) are key factors driving the growth of this market. The changing preference of patients towards home care devices is expected to propel the growth of anesthesia and respiratory care devices market.

“By Region, Europe holds the second largest share in the top 10 Medical Device Technologies market, in the forecast period”

By Region, In 2021, Europe accounted for the second largest share of the top 10 Medical Device Technologies market in the forecast period, followed by the Asia Pacific, Latin America, and the Middle East & Africa. This is mainly attributed to the demand for advanced Medical Device Technologies and the presence of leading players in this region. Factors such as the Eurozone debt crisis and uncertainty and variations in reimbursement across the region may hamper the growth of this market to a certain extent.

A breakdown of the primary participants for the top 10 Medical Device Technologies market referred to for this report is provided below:
  • By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
  • By Designation: C-level–35%, Director Level–25%, and Others–40%
  • By Region: North America–40%, Asia- Pacific–30%, Europe–20%, Middle East & Africa–5%, Latin America- 5%
The prominent players in the global top 10 Medical Device Technologies market are Abbott Laboratories, Inc. (US), Roche Diagnostics (Switzerland), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Stryker Corporation (US), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic PLC (Ireland), Smith & Nephew PLC (UK), GE Healthcare (US).

Research Coverage:

This research report categorizes the top 10 Medical Device Technologies market by type and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the top 10 Medical Device Technologies market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the top 10 Medical Device Technologies market. Competitive analysis of upcoming startups in the top 10 Medical Device Technologies market ecosystem is covered in this report.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall top 10 Medical Device Technologies market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global top 10 Medical Device Technologies market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global top 10 Medical Device Technologies market
  • Market Development: Comprehensive information on the lucrative emerging regions by type and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global top 10 Medical Device Technologies market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global top 10 Medical Device Technologies market.
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
FIGURE 1 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET
  1.3.2 REGIONAL SCOPE
  1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 BOTTOM-UP APPROACH
FIGURE 7 TOP-DOWN APPROACH
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET
2.8 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET

3 EXECUTIVE SUMMARY

FIGURE 10 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2022–2027
FIGURE 11 RESPIRATORY CARE AND ANESTHESIA DEVICES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 12 IN VITRO DIAGNOSTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 CARDIOLOGY DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GEOGRAPHIC SNAPSHOT OF TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET

4 PREMIUM INSIGHTS

4.1 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET OVERVIEW
FIGURE 17 INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
4.2 10 MEDICAL DEVICE TECHNOLOGIES MARKET: GROWTH OPPORTUNITIES, BY COUNTRY
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
4.3 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY REGION (2020–2027)
FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN 2027
4.4 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: DEVELOPED VS. DEVELOPING COUNTRIES
FIGURE 20 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Rising prevalence of chronic diseases and related increase in disability-adjusted life years
TABLE 3 PROJECTED DISABILITY-ADJUSTED LIFE YEARS ACROSS VARIOUS REGIONS, BY CAUSE, 2015 VS. 2030 (MILLION YEARS)
TABLE 4 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65 YEARS AND OVER), 2020 VS. 2040
    5.2.1.2 Technological advancements in medical devices
    5.2.1.3 Rapidly increasing geriatric population
FIGURE 22 SHARE OF GERIATRIC POPULATION, BY REGION, 2015 VS. 2030
  5.2.2 RESTRAINTS
    5.2.2.1 Uncertainty in reimbursement
    5.2.2.2 Excise tax on medical devices in US
  5.2.3 OPPORTUNITIES
    5.2.3.1 Increasing investments from government bodies and private players in healthcare sectors in emerging economies
    5.2.3.2 Increasing focus of key players on medical devices market in emerging countries
  5.2.4 CHALLENGES
    5.2.4.1 High cost of medical devices and implants
    5.2.4.2 Hospital budget cuts
    5.2.4.3 Increasing adoption of refurbished medical devices

6 IN VITRO DIAGNOSTICS MARKET

6.1 INTRODUCTION
6.2 MARKET DYNAMICS
FIGURE 23 IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  6.2.1 DRIVERS
    6.2.1.1 Gradual shift from centralized testing to point-of-care testing
    6.2.1.2 Growing awareness of early disease diagnosis in emerging economies
    6.2.1.3 Emergence of rapid PoC diagnostics and rising adoption of automated analyzers
TABLE 5 IN VITRO DIAGNOSTICS MARKET: PRODUCT LAUNCHES (2020?2022)
  6.2.2 RESTRAINTS
    6.2.2.1 Unfavorable reimbursement scenario
  6.2.3 OPPORTUNITIES
    6.2.3.1 Introduction of disease-specific biomarkers and tests
TABLE 6 APPLICATION OF CANCER BIOMARKERS IN CLINICAL PRACTICE
    6.2.3.2 Growing significance of companion diagnostics
  6.2.4 CHALLENGES
    6.2.4.1 Stringent regulatory and legal guidelines
FIGURE 24 IVDR: KEY AREAS OF IMPACT
TABLE 7 IVD MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 8 IVD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 IMMUNOASSAY/IMMUNOCHEMISTRY
  6.3.1 RISING TREND OF AUTOMATION TO DRIVE MARKET
TABLE 9 KEY IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE IN IVD MARKET
TABLE 10 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 CLINICAL CHEMISTRY
  6.4.1 INCREASING INCIDENCE OF LIFESTYLE DISEASES TO PROPEL MARKET
TABLE 11 CLINICAL CHEMISTRY ANALYZERS FOR HIGH AND MID-VOLUME LABORATORIES
TABLE 12 CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES
TABLE 13 CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 MOLECULAR DIAGNOSTICS
  6.5.1 RISING PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
TABLE 14 KEY AUTOMATED MOLECULAR DIAGNOSTIC PLATFORMS AVAILABLE IN IVD MARKET
TABLE 15 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 HEMATOLOGY
  6.6.1 INCREASING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET
TABLE 16 KEY HEMATOLOGY ANALYZERS AVAILABLE IN IVD MARKET
TABLE 17 HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 MICROBIOLOGY
  6.7.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO DRIVE MARKET
TABLE 18 KEY MICROBIOLOGY INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 19 MICROBIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.8 COAGULATION AND HEMOSTASIS
  6.8.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET
TABLE 20 KEY COAGULATION ANALYZERS AVAILABLE IN IVD MARKET
TABLE 21 KEY POINT-OF-CARE/SELF-MONITORING COAGULATION ANALYZERS AVAILABLE IN IVD MARKET
TABLE 22 COAGULATION AND HEMOSTASIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.9 URINALYSIS
  6.9.1 RISING PREVALENCE OF KIDNEY DISORDERS AND UTIS TO SUPPORT MARKET GROWTH
TABLE 23 KEY URINALYSIS INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 24 URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.10 OTHER IVD TECHNOLOGIES
TABLE 25 KEY BLOOD GLUCOSE TESTING SYSTEMS AVAILABLE IN IVD MARKET
TABLE 26 TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS AVAILABLE IN IVD MARKET
TABLE 27 OTHER IVD TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 CARDIOLOGY DEVICES MARKET

7.1 INTRODUCTION
7.2 MARKET DYNAMICS
FIGURE 25 CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  7.2.1 DRIVERS
    7.2.1.1 Increasing incidence of cardiovascular diseases
    7.2.1.2 Launch of innovative products by market players
  7.2.2 RESTRAINTS
    7.2.2.1 Low affordability and inaccessibility of cardiac surgeries in developing countries
  7.2.3 OPPORTUNITIES
    7.2.3.1 Growth potential of emerging economies
  7.2.4 CHALLENGES
    7.2.4.1 Stringent regulatory requirements delaying approval of cardiac devices
TABLE 28 CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 CARDIOVASCULAR MONITORING DEVICES
  7.3.1 INCREASING ACCEPTANCE OF REMOTE MONITORING DEVICES TO PROPEL MARKET GROWTH
TABLE 30 CARDIOVASCULAR MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 CARDIAC RHYTHM MANAGEMENT DEVICES
  7.4.1 TECHNOLOGICAL IMPROVEMENTS IN PACEMAKERS TO SUPPORT MARKET GROWTH
TABLE 31 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 INTERVENTIONAL CARDIOLOGY DEVICES
  7.5.1 USED FOR DIAGNOSIS AND TREATMENT OF ARTERIAL BLOCKAGES
TABLE 32 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 PERIPHERAL VASCULAR DEVICES
  7.6.1 EMERGENCE OF ADVANCED FLOW ALTERATION DEVICES TO SUPPORT MARKET GROWTH
TABLE 33 PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 PROSTHETIC DEVICES
  7.7.1 STRINGENT APPROVAL PROCESS TO RESTRAIN MARKET GROWTH
TABLE 34 PROSTHETIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 ELECTROPHYSIOLOGY DEVICES
  7.8.1 LACK OF SKILLED AND EXPERIENCED ELECTROPHYSIOLOGISTS TO RESTRAIN MARKET GROWTH
TABLE 35 ELECTROPHYSIOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 DIAGNOSTIC IMAGING DEVICES MARKET

8.1 INTRODUCTION
8.2 MARKET DYNAMICS
FIGURE 26 DIAGNOSTIC IMAGING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  8.2.1 DRIVERS
    8.2.1.1 Growing geriatric population and rising prevalence of associated diseases
TABLE 36 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES
    8.2.1.2 Technological advancements in diagnostic imaging modalities
TABLE 37 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING SYSTEMS
  8.2.2 RESTRAINTS
    8.2.2.1 High cost of diagnostic imaging systems
  8.2.3 OPPORTUNITIES
    8.2.3.1 Adoption of AI and analytics in diagnostic imaging
  8.2.4 CHALLENGES
    8.2.4.1 Hospital budget cuts
TABLE 38 DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 DIAGNOSTIC IMAGING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 ULTRASOUND SYSTEMS
  8.3.1 TECHNOLOGICAL AND SOFTWARE MODIFICATIONS IN ULTRASOUND TECHNOLOGY TO DRIVE MARKET
TABLE 40 ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 X-RAY SYSTEMS
  8.4.1 EASY ACCESSIBILITY AND ADEQUACY OF X-RAY DEVICES TO PROPEL MARKET
TABLE 41 X-RAY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 NUCLEAR IMAGING EQUIPMENT
  8.5.1 HIGH COST OF NUCLEAR IMAGING EQUIPMENT TO RESTRAIN MARKET GROWTH
TABLE 42 NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.6 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
  8.6.1 SAFETY ISSUES ASSOCIATED TO HAMPER MARKET GROWTH
TABLE 43 MAGNETIC RESONANCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.7 COMPUTED TOMOGRAPHY (CT) SCANNERS
  8.7.1 GROWING APPLICATIONS OF CT SCANNERS TO DRIVE MARKET
TABLE 44 COMPUTED TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.8 MAMMOGRAPHY SYSTEMS
  8.8.1 MAMMOGRAPHY SYSTEMS SEGMENT TO GROW AT HIGHEST CAGR
TABLE 45 MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

9 ORTHOPEDIC DEVICES MARKET

9.1 INTRODUCTION
9.2 MARKET DYNAMICS
FIGURE 27 ORTHOPEDIC DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  9.2.1 DRIVERS
    9.2.1.1 Increasing prevalence of orthopedic diseases and disorders
    9.2.1.2 Rising number of sports and accident-related orthopedic injuries
  9.2.2 RESTRAINTS
    9.2.2.1 High cost associated with orthopedic treatments
  9.2.3 OPPORTUNITIES
    9.2.3.1 Increasing use of robotics and 3D printing in orthopedics
  9.2.4 CHALLENGES
    9.2.4.1 Dearth of orthopedic surgeons
TABLE 46 ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 ORTHOPEDIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 ORTHOBIOLOGICS
  9.3.1 RISING INCIDENCE OF DEFORMITIES AND TRAUMA IN SMALL EXTREMITIES TO DRIVE MARKET
TABLE 48 ORTHOBIOLOGICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 JOINT RECONSTRUCTION DEVICES
  9.4.1 INCREASING PARTICIPATION IN SPORTS TO BOOST ADOPTION
TABLE 49 JOINT RECONSTRUCTION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 SPINAL SURGERY DEVICES
  9.5.1 INCREASING INCIDENCE OF SPINAL DEFORMITIES TO DRIVE ADOPTION
TABLE 50 SPINAL SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.6 TRAUMA FIXATION PRODUCTS
  9.6.1 INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET
TABLE 51 TRAUMA FIXATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.7 ARTHROSCOPIC DEVICES
  9.7.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO SUPPORT MARKET GROWTH
TABLE 52 ARTHROSCOPIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.8 ORTHOPEDIC ACCESSORIES
  9.8.1 INCREASING PREVALENCE OF RHEUMATOID DISEASES AND OSTEOARTHRITIS TO PROPEL MARKET
TABLE 53 ORTHOPEDIC ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.9 ORTHOPEDIC BRACES AND SUPPORTS
  9.9.1 RISING PREVALENCE OF ORTHOPEDIC INJURIES AND DISORDERS TO PROPEL MARKET
TABLE 54 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

10 OPHTHALMOLOGY DEVICES MARKET

10.1 INTRODUCTION
10.2 MARKET DYNAMICS
FIGURE 28 OPHTHALMOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  10.2.1 DRIVERS
    10.2.1.1 Rising prevalence of eye disorders
TABLE 55 PREVALENCE OF EYE DISORDERS, BY TYPE, 2021 (IN MILLION)
      10.2.1.1.1 Cataracts
TABLE 56 NUMBER OF CATARACT SURGERIES, BY COUNTRY, 2020 VS. 2021
      10.2.1.1.2 Glaucoma
TABLE 57 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS 2040 (IN MILLION)
      10.2.1.1.3 Obesity and diabetes
TABLE 58 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS. 2045 (MILLION)
      10.2.1.1.4 Age-related macular degeneration (AMD)
TABLE 59 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS. 2050 (MILLION)
    10.2.1.2 Technological advancements in ophthalmic devices
TABLE 60 RECENT PRODUCT LAUNCHES IN OPHTHALMOLOGY DEVICES MARKET (2020–2021)
  10.2.2 RESTRAINTS
    10.2.2.1 High cost and risk associated with eye surgeries
  10.2.3 OPPORTUNITIES
    10.2.3.1 Low adoption of phacoemulsification devices and premium IOLs in emerging regions
  10.2.4 CHALLENGES
    10.2.4.1 Low accessibility to eye care in low-income countries
TABLE 61 OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 OPHTHALMOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.3 OPHTHALMIC DIAGNOSTIC AND MONITORING DEVICES
  10.3.1 INCREASING INCIDENCE AND PREVALENCE OF OPHTHALMIC DISORDERS TO DRIVE MARKET
TABLE 63 OPHTHALMIC DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.4 REFRACTIVE SURGERY DEVICES
  10.4.1 RISING PREVALENCE OF UNCORRECTED REFRACTIVE ERRORS TO SUPPORT MARKET GROWTH
TABLE 64 REFRACTIVE SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.5 GLAUCOMA SURGERY DEVICES
  10.5.1 RISING GERIATRIC POPULATION TO PROPEL ADOPTION
TABLE 65 GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.6 CATARACT SURGERY DEVICES
  10.6.1 FAVORABLE REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES TO SUPPORT MARKET GROWTH
TABLE 66 CATARACT SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.7 VITREORETINAL SURGERY DEVICES
  10.7.1 INCREASING PREVALENCE OF DIABETIC RETINOPATHY AND AMD SURGERY DEVICES TO SUPPORT MARKET GROWTH
TABLE 67 VITREORETINAL SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.8 VISION CARE DEVICES
  10.8.1 TECHNOLOGICAL ADVANCEMENTS IN LENS MATERIALS TO DRIVE MARKET
TABLE 68 VISION CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

11 ENDOSCOPY DEVICES MARKET

11.1 INTRODUCTION
11.2 MARKET DYNAMICS
FIGURE 29 ENDOSCOPY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  11.2.1 DRIVERS
    11.2.1.1 Surging requirement for endoscopy to diagnose and treat target diseases
FIGURE 30 UK: NUMBER OF ANNUAL PLANNED ENDOSCOPY SESSIONS PER INDIVIDUAL
    11.2.1.2 Adoption of single-use endoscopy instruments to prevent infectious diseases
  11.2.2 RESTRAINTS
    11.2.2.1 High overhead cost of endoscopy procedures with limited reimbursement in developing countries
  11.2.3 OPPORTUNITIES
    11.2.3.1 Booming healthcare sector in developing economies
  11.2.4 CHALLENGES
    11.2.4.1 Infections caused by some endoscopy products offered by giant companies
TABLE 69 ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
11.3 ENDOSCOPES
TABLE 71 ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.3.1 RIGID ENDOSCOPES
    11.3.1.1 Growing demand for minimally invasive surgical procedures to propel market growth
TABLE 73 RIGID ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.3.2 FLEXIBLE ENDOSCOPES
    11.3.2.1 Rising prevalence of colorectal cancer to support market growth
TABLE 74 FLEXIBLE ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.3.3 ROBOT-ASSISTED ENDOSCOPES
    11.3.3.1 Technological advancements to support market growth
TABLE 75 ROBOT-ASSISTED ENDOSCOPE PRODUCTS
TABLE 76 ROBOT-ASSISTED ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.3.4 DISPOSABLE ENDOSCOPES
    11.3.4.1 Strong focus on preventing hospital-acquired infections to increase demand
TABLE 77 INDICATIVE LIST OF DISPOSABLE ENDOSCOPE MANUFACTURERS
TABLE 78 DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.3.5 CAPSULE ENDOSCOPES
    11.3.5.1 Favorable reimbursement policies to support market growth
TABLE 79 INDICATIVE LIST OF CAPSULE ENDOSCOPE MANUFACTURERS
TABLE 80 CAPSULE ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
11.4 VISUALIZATION EQUIPMENT
TABLE 81 VISUALIZATION EQUIPMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 VISUALIZATION EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.1 WIRELESS DISPLAYS AND MONITORS
    11.4.1.1 Use of wireless displays and monitors reduces cost of routing cables through ceilings in hospitals
TABLE 83 WIRELESS DISPLAYS AND MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.2 ENDOSCOPIC LIGHT SOURCES
    11.4.2.1 Light sources are critical components of endoscopy visualization systems
TABLE 84 ENDOSCOPIC LIGHT SOURCES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.3 VIDEO CONVERTERS
    11.4.3.1 Need for high-resolution images and videos to propel market
TABLE 85 VIDEO CONVERTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.4 VIDEO RECORDERS
    11.4.4.1 Necessity to document patient data to drive market
TABLE 86 VIDEO RECORDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.5 VIDEO PROCESSORS
    11.4.5.1 Sort electric signals transmitted by camera head according to pixel location and intensity
TABLE 87 VIDEO PROCESSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.6 CAMERA HEADS
    11.4.6.1 Technological advancements in camera technology to propel market
TABLE 88 CAMERA HEADS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.7 TRANSMITTERS AND RECEIVERS
    11.4.7.1 Wireless transmitters and receivers ensure operating room safety and efficiency
TABLE 89 TRANSMITTERS AND RECEIVERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.8 CARTS
    11.4.8.1 Surge in demand for endoscopy systems to fuel demand
TABLE 90 CARTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.4.9 OTHER VISUALIZATION EQUIPMENT
TABLE 91 OTHER VISUALIZATION EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
11.5 ENDOSCOPIC ACCESSORIES
  11.5.1 GROWING NUMBER OF ENDOSCOPIC PROCEDURES TO PROPEL ADOPTION
TABLE 92 ENDOSCOPY ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
11.6 OTHER ENDOSCOPY EQUIPMENT
TABLE 93 OTHER ENDOSCOPY EQUIPMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 OTHER ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.6.1 ELECTRONIC ENDOSCOPY EQUIPMENT
    11.6.1.1 Enable surgeons to perform procedures with ease
TABLE 95 ELECTRONIC ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  11.6.2 MECHANICAL ENDOSCOPY EQUIPMENT
    11.6.2.1 Increasing number of endoscopy procedures to drive market
TABLE 96 MECHANICAL ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

12 DIABETES CARE DEVICES MARKET

12.1 INTRODUCTION
12.2 MARKET DYNAMICS
FIGURE 31 DIABETES CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  12.2.1 DRIVERS
    12.2.1.1 Global rise in diabetic population
    12.2.1.2 Technological advancements in diabetes care devices
  12.2.2 RESTRAINTS
    12.2.2.1 High cost of devices and lack of reimbursement in developing countries
  12.2.3 OPPORTUNITIES
    12.2.3.1 Increasing diabetes-related health expenditure
  12.2.4 CHALLENGES
    12.2.4.1 Pricing pressure
TABLE 97 DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
12.3 BLOOD GLUCOSE MONITORING SYSTEMS
  12.3.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET
TABLE 99 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
12.4 INSULIN DELIVERY DEVICES
  12.4.1 RISING AWARENESS OF DIABETES AND IMPROVING HEALTHCARE FACILITIES IN DEVELOPING COUNTRIES TO DRIVE MARKET
TABLE 100 INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
12.5 DIABETES MANAGEMENT MOBILE APPLICATIONS
  12.5.1 GROWING ADOPTION OF BLOOD GLUCOSE TRACKING APPS TO SUPPORT MARKET GROWTH
TABLE 101 DIABETES MANAGEMENT MOBILE APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

13 WOUND CARE DEVICES MARKET

13.1 INTRODUCTION
13.2 MARKET DYNAMICS
FIGURE 32 WOUND CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  13.2.1 DRIVERS
    13.2.1.1 Growing prevalence of diseases and health conditions that affect wound healing capabilities
    13.2.1.2 Technological advancements in wound care products
  13.2.2 RESTRAINTS
    13.2.2.1 Risks associated with use of advanced wound care products
TABLE 102 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
  13.2.3 OPPORTUNITIES
    13.2.3.1 Growth potential of emerging countries
TABLE 103 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC REGION
  13.2.4 CHALLENGES
    13.2.4.1 High cost of advanced wound care products
TABLE 104 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
TABLE 105 WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
13.3 ADVANCED WOUND CARE DEVICES
  13.3.1 INCREASING INCIDENCE OF DIABETIC ULCERS TO PROPEL MARKET
TABLE 107 ADVANCED WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
13.4 SURGICAL WOUND CARE DEVICES
  13.4.1 GROWING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
TABLE 108 SURGICAL WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
13.5 TRADITIONAL WOUND CARE DEVICES
  13.5.1 RISING INCIDENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
TABLE 109 TRADITIONAL WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

14 KIDNEY/DIALYSIS DEVICES MARKET

14.1 INTRODUCTION
14.2 MARKET DYNAMICS
FIGURE 33 KIDNEY/DIALYSIS DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  14.2.1 DRIVERS
    14.2.1.1 Increasing number of ESRD patients
TABLE 110 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 VS. 2050
    14.2.1.2 Growing prevalence of diabetes and hypertension
  14.2.2 RESTRAINTS
    14.2.2.1 Risks and complications of dialysis
  14.2.3 OPPORTUNITIES
    14.2.3.1 Increasing number of dialysis centers
  14.2.4 CHALLENGES
    14.2.4.1 Benefits of renal transplantation
      14.2.4.1.1 Low cost
      14.2.4.1.2 Better survival rate
TABLE 111 KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 KIDNEY/DIALYSIS DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
14.3 HEMODIALYSIS PRODUCTS
TABLE 113 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.3.1 HEMODIALYSIS MACHINES
    14.3.1.1 Presence of large ESRD patient population to drive market
TABLE 115 HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.3.2 HEMODIALYSIS CONSUMABLES/SUPPLIES
    14.3.2.1 Increasing number of ESRD patients to support market growth
TABLE 116 HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
14.4 PERITONEAL DIALYSIS PRODUCTS
TABLE 117 PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.4.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
    14.4.1.1 High demand for PD concentrates prompted players to focus on improving their manufacturing capabilities
TABLE 119 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.4.2 PERITONEAL DIALYSIS MACHINES
    14.4.2.1 Rising prevalence of chronic diseases in emerging countries to boost adoption of home peritoneal dialysis
TABLE 120 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.4.3 PERITONEAL DIALYSIS CATHETERS
    14.4.3.1 Favorable changes in reimbursement policies for PD catheters to support market growth
TABLE 121 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.4.4 PERITONEAL DIALYSIS TRANSFER SETS
    14.4.4.1 Shift toward home dialysis to increase adoption of PD transfer sets
TABLE 122 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  14.4.5 OTHER PERITONEAL DIALYSIS PRODUCTS
TABLE 123 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

15 ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET

15.1 INTRODUCTION
15.2 MARKET DYNAMICS
FIGURE 34 RESPIRATORY CARE AND ANESTHESIA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  15.2.1 DRIVERS
    15.2.1.1 Rising prevalence of respiratory diseases
    15.2.1.2 Increasing incidence of preterm births
  15.2.2 RESTRAINTS
    15.2.2.1 Unfavorable reimbursement scenario
  15.2.3 OPPORTUNITIES
    15.2.3.1 High growth in developing countries across Asia Pacific and Latin America
  15.2.4 CHALLENGES
    15.2.4.1 Harmful effects of certain devices on neonates
TABLE 124 ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
15.3 ANESTHESIA DEVICES
TABLE 126 ANESTHESIA DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 ANESTHESIA DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  15.3.1 ANESTHESIA MACHINES
    15.3.1.1 Demand for technologically advanced machines to propel market
TABLE 128 ANESTHESIA MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  15.3.2 ANESTHESIA DISPOSABLES
    15.3.2.1 Increasing number of surgical procedures to support market growth
TABLE 129 ANESTHESIA DISPOSABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
15.4 RESPIRATORY CARE DEVICES
TABLE 130 RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  15.4.1 RESPIRATORY DEVICES
TABLE 132 RESPIRATORY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 RESPIRATORY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.1 Humidifiers
      15.4.1.1.1 Ensure optimum respiratory gas supply to ventilated patients
TABLE 134 HUMIDIFIERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.2 Nebulizers
      15.4.1.2.1 Lower cost, ease of use, and long-term durability to support adoption
TABLE 135 NEBULIZERS AVAILABLE IN MARKET
TABLE 136 NEBULIZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.3 Oxygen concentrators
      15.4.1.3.1 Increasing incidence of respiratory diseases to drive market
TABLE 137 OXYGEN CONCENTRATORS AVAILABLE IN MARKET
TABLE 138 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.4 PAP devices
      15.4.1.4.1 Availability of reimbursement to favor market growth
TABLE 139 PAP DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.5 Reusable resuscitators
      15.4.1.5.1 More economical in long run
TABLE 140 REUSABLE RESUSCITATORS OFFERED BY MAJOR PLAYERS
TABLE 141 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.6 Ventilators
      15.4.1.6.1 Increasing ICU admissions to support market growth
TABLE 142 VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.1.7 Inhalers
      15.4.1.7.1 Widely used in treatment of major respiratory ailments
TABLE 143 INHALERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  15.4.2 RESPIRATORY DISPOSABLES
TABLE 144 RESPIRATORY DISPOSABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 RESPIRATORY DISPOSABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.2.1 Disposable oxygen masks
      15.4.2.1.1 Increasing patient population for respiratory diseases to drive adoption
TABLE 146 DISPOSABLE OXYGEN MASKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.2.2 Resuscitators
      15.4.2.2.1 Technological advancements to propel adoption
TABLE 147 RESUSCITATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.2.3 Tracheostomy tubes
      15.4.2.3.1 Introduction of new and advanced products with ergonomic designs to drive market
TABLE 148 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.2.4 Oxygen cannulas
      15.4.2.4.1 Increasing demand for minimally invasive surgeries to boost demand
TABLE 149 OXYGEN CANNULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  15.4.3 RESPIRATORY MEASUREMENT DEVICES
TABLE 150 RESPIRATORY MEASUREMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 RESPIRATORY MEASUREMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.3.1 Pulse oximetry systems
      15.4.3.1.1 Rising adoption in home care settings to support market growth
TABLE 152 PULSE OXIMETER SYSTEMS OFFERED BY MAJOR PLAYERS
TABLE 153 PULSE OXIMETER SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.3.2 Capnographs
      15.4.3.2.1 Extensive research to result in development of improved capnographs
TABLE 154 CAPNOGRAPHS OFFERED BY MAJOR PLAYERS
TABLE 155 CAPNOGRAPHS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.3.3 Spirometers
      15.4.3.3.1 Technological advancements to increase adoption
TABLE 156 SPIROMETERS OFFERED BY MAJOR PLAYERS
TABLE 157 SPIROMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    15.4.3.4 Peak flow meters
      15.4.3.4.1 Not preferred in hospitals due to high variability in measurements obtained
TABLE 158 PEAK FLOW METERS OFFERED BY VARIOUS PLAYERS
TABLE 159 PEAK FLOW METERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

16 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY REGION

16.1 INTRODUCTION
FIGURE 35 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 160 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)
16.2 NORTH AMERICA
  16.2.1 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN NORTH AMERICA
FIGURE 36 NORTH AMERICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET SNAPSHOT
TABLE 161 NORTH AMERICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 162 NORTH AMERICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 NORTH AMERICA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 NORTH AMERICA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 NORTH AMERICA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 NORTH AMERICA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 NORTH AMERICA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 NORTH AMERICA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 NORTH AMERICA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.2.2 US
    16.2.2.1 High healthcare expenditure to favor market growth
TABLE 173 US: KEY MACROINDICATORS
TABLE 174 US: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 US: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 US: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 US: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 US: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 US: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 US: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 US: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 US: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 US: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.2.3 CANADA
    16.2.3.1 Growing awareness about early disease diagnosis to drive market
TABLE 185 CANADA: KEY MACROINDICATORS
TABLE 186 CANADA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 CANADA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 CANADA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 CANADA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 CANADA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 CANADA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 CANADA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 CANADA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 CANADA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 CANADA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
16.3 EUROPE
  16.3.1 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN EUROPE
TABLE 197 EUROPE: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 198 EUROPE: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 EUROPE: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 EUROPE: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 EUROPE: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 EUROPE: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 EUROPE: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 EUROPE: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 EUROPE: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 EUROPE: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 208 EUROPE: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.3.2 GERMANY
    16.3.2.1 Higher healthcare spending to favor market growth
TABLE 209 GERMANY: KEY MACROINDICATORS
TABLE 210 GERMANY: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 GERMANY: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 GERMANY: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 GERMANY: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 GERMANY: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 GERMANY: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 217 GERMANY: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 GERMANY: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 GERMANY: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 GERMANY: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.3.3 FRANCE
    16.3.3.1 Modernization of healthcare infrastructure to fuel market growth
TABLE 221 FRANCE: KEY MACROINDICATORS
TABLE 222 FRANCE: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 223 FRANCE: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 FRANCE: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 225 FRANCE: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 FRANCE: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 FRANCE: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 228 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 FRANCE: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 230 FRANCE: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 231 FRANCE: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 232 FRANCE: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.3.4 UK
    16.3.4.1 Rising geriatric population to drive market
TABLE 233 UK: KEY MACROINDICATORS
TABLE 234 UK: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 UK: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 236 UK: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 UK: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 238 UK: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 239 UK: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 240 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 241 UK: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 242 UK: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 243 UK: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 244 UK: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.3.5 ITALY
    16.3.5.1 Improved reimbursement scenario to support market growth
TABLE 245 ITALY: KEY MACROINDICATORS
TABLE 246 ITALY: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 ITALY: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 248 ITALY: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 249 ITALY: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 250 ITALY: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 ITALY: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 252 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 253 ITALY: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 254 ITALY: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 255 ITALY: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 256 ITALY: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.3.6 SPAIN
    16.3.6.1 Developing healthcare facilities and infrastructure to support market growth
TABLE 257 SPAIN: KEY MACROINDICATORS
TABLE 258 SPAIN: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 259 SPAIN: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 260 SPAIN: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 261 SPAIN: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 262 SPAIN: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 263 SPAIN: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 265 SPAIN: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 266 SPAIN: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 SPAIN: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 268 SPAIN: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.3.7 REST OF EUROPE
TABLE 269 REST OF EUROPE: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 270 REST OF EUROPE: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 271 REST OF EUROPE: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 272 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 273 REST OF EUROPE: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 274 REST OF EUROPE: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 275 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 276 REST OF EUROPE: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 REST OF EUROPE: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 278 REST OF EUROPE: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 279 REST OF EUROPE: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
16.4 ASIA PACIFIC
  16.4.1 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN ASIA PACIFIC
FIGURE 37 ASIA PACIFIC: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET SNAPSHOT
TABLE 280 ASIA PACIFIC: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 281 ASIA PACIFIC: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 282 ASIA PACIFIC: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 283 ASIA PACIFIC: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 284 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 285 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 286 ASIA PACIFIC: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 287 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 288 ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 ASIA PACIFIC: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 ASIA PACIFIC: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 ASIA PACIFIC: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.4.2 CHINA
    16.4.2.1 Increasing patient pool to drive market
TABLE 292 CHINA: KEY MACROINDICATORS
TABLE 293 CHINA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 294 CHINA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 295 CHINA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 296 CHINA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 297 CHINA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 298 CHINA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 299 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 CHINA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 CHINA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 302 CHINA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 CHINA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.4.3 JAPAN
    16.4.3.1 Rising geriatric population to propel market growth
TABLE 304 JAPAN: KEY MACROINDICATORS
TABLE 305 JAPAN: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 306 JAPAN: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 307 JAPAN: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 JAPAN: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 JAPAN: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 JAPAN: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 311 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 312 JAPAN: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 313 JAPAN: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 314 JAPAN: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 315 JAPAN: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.4.4 INDIA
    16.4.4.1 High burden of target diseases and availability of affordable devices to support market growth
TABLE 316 INDIA: KEY MACROINDICATORS
TABLE 317 INDIA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 318 INDIA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 319 INDIA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 320 INDIA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 321 INDIA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 322 INDIA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 323 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 324 INDIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 325 INDIA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 326 INDIA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 327 INDIA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.4.5 REST OF ASIA PACIFIC
TABLE 328 REST OF ASIA PACIFIC: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 334 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 335 REST OF ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 336 REST OF ASIA PACIFIC: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 337 REST OF ASIA PACIFIC: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 338 REST OF ASIA PACIFIC: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
16.5 LATIN AMERICA
  16.5.1 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN LATIN AMERICA
TABLE 339 LATIN AMERICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 340 LATIN AMERICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 341 LATIN AMERICA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 342 LATIN AMERICA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 343 LATIN AMERICA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 344 LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 345 LATIN AMERICA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 346 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 347 LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 348 LATIN AMERICA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 349 LATIN AMERICA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 350 LATIN AMERICA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.5.2 BRAZIL
    16.5.2.1 Universal healthcare system to drive market
TABLE 351 BRAZIL: KEY MACROINDICATORS
TABLE 352 BRAZIL: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 353 BRAZIL: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 354 BRAZIL: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 355 BRAZIL: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 356 BRAZIL: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 357 BRAZIL: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 358 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 359 BRAZIL: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 360 BRAZIL: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 361 BRAZIL: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 362 BRAZIL: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.5.3 MEXICO
    16.5.3.1 Modernization of healthcare infrastructure to support market growth
TABLE 363 MEXICO: KEY MACROINDICATORS
TABLE 364 MEXICO: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 365 MEXICO: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 366 MEXICO: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 367 MEXICO: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 368 MEXICO: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 369 MEXICO: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 370 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 371 MEXICO: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 372 MEXICO: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 373 MEXICO: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 374 MEXICO: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
  16.5.4 REST OF LATIN AMERICA
TABLE 375 REST OF LATIN AMERICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 376 REST OF LATIN AMERICA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 377 REST OF LATIN AMERICA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 378 REST OF LATIN AMERICA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 379 REST OF LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 380 REST OF LATIN AMERICA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 381 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 382 REST OF LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 383 REST OF LATIN AMERICA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 384 REST OF LATIN AMERICA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 385 REST OF LATIN AMERICA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
16.6 MIDDLE EAST & AFRICA
  16.6.1 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN MIDDLE EAST & AFRICA
TABLE 386 MIDDLE EAST AND AFRICA: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 387 MIDDLE EAST AND AFRICA: IVD DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 388 MIDDLE EAST AND AFRICA: CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 389 MIDDLE EAST AND AFRICA: DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 390 MIDDLE EAST AND AFRICA: ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 391 MIDDLE EAST AND AFRICA: OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 392 MIDDLE EAST AND AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 393 MIDDLE EAST AND AFRICA: DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 394 MIDDLE EAST AND AFRICA: WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 395 MIDDLE EAST AND AFRICA: KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 396 MIDDLE EAST AND AFRICA: ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)

17 COMPETITIVE LANDSCAPE

17.1 INTRODUCTION
FIGURE 38 STRATEGIES ADOPTED BY KEY PLAYERS
17.2 MARKET SHARE ANALYSIS
  17.2.1 IN VITRO DIAGNOSTICS MARKET
FIGURE 39 IN VITRO DIAGNOSTICS MARKET SHARE, BY KEY PLAYER (2021)
  17.2.2 CARDIOLOGY DEVICES MARKET
FIGURE 40 CARDIOLOGY DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.3 DIAGNOSTIC IMAGING DEVICES MARKET
FIGURE 41 DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.4 ORTHOPEDIC DEVICES MARKET
FIGURE 42 ORTHOPEDIC DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.5 OPHTHALMOLOGY DEVICES MARKET
FIGURE 43 OPHTHALMOLOGY DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.6 ENDOSCOPY DEVICES MARKET
FIGURE 44 ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.7 DIABETES CARE DEVICES MARKET
FIGURE 45 DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.8 WOUND CARE DEVICES MARKET
FIGURE 46 WOUND CARE DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.9 KIDNEY/DIALYSIS DEVICES MARKET
FIGURE 47 KIDNEY/DIALYSIS DEVICES MARKET SHARE, BY KEY PLAYER (2021)
  17.2.10 RESPIRATORY CARE AND ANESTHESIA DEVICES MARKET
FIGURE 48 RESPIRATORY CARE AND ANESTHESIA DEVICES MARKET SHARE, BY KEY PLAYER (2021)
17.3 COMPETITIVE SCENARIO
  17.3.1 PRODUCT LAUNCHES
TABLE 397 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: PRODUCT LAUNCHES (JANUARY 2020–APRIL 2023)
  17.3.2 DEALS
TABLE 398 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: DEALS (JANUARY 2020–APRIL 2023)
  17.3.3 OTHER DEVELOPMENTS
TABLE 399 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: OTHER DEVELOPMENTS (JANUARY 2020–APRIL 2023)
17.4 R&D ASSESSMENT OF KEY PLAYERS
FIGURE 49 R&D EXPENDITURE OF KEY PLAYERS IN TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET (2021 VS. 2022)
17.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
FIGURE 50 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS IN TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET (2021)

18 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
18.1 ABBOTT LABORATORIES
  18.1.1 BUSINESS OVERVIEW
TABLE 400 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 51 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
  18.1.2 PRODUCTS OFFERED
  18.1.3 RECENT DEVELOPMENTS
  18.1.4 MNM VIEW
18.2 ROCHE DIAGNOSTICS
TABLE 401 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 52 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2022)
18.3 KONINKLIJKE PHILIPS N.V.
TABLE 402 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
18.4 SIEMENS HEALTHINEERS
TABLE 403 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 54 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
18.5 STRYKER CORPORATION
TABLE 404 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 55 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
18.6 BOSTON SCIENTIFIC CORPORATION
TABLE 405 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 56 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
18.7 JOHNSON & JOHNSON
TABLE 406 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 57 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
18.8 MEDTRONIC PLC
TABLE 407 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 58 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
18.9 SMITH & NEPHEW PLC
TABLE 408 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 59 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2022)
18.10 GE HEALTHCARE
TABLE 409 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
FIGURE 60 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

19 APPENDIX

19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS


More Publications